-
Mashup Score: 12Papa Heme Talks Castleman Disease Next #HemOncPulse With #ChadiNabhan @bloodcancerstoday2935 - 21 day(s) ago
Aaron Goodman, MD, of the University of California, San Diego Health gives a 360-degree view on Castleman disease on the next episode of The HemOnc Pulse on …
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Hematology and Oncology Fellow Education About Sexual and Reproductive Health: A Survey of Program Directors in the United States - 2 month(s) ago
PURPOSE Clinical oncology guidelines recommend addressing sexual and reproductive health (SRH) concerns in routine cancer care. However, limited training often hinders clinicians’ ability to do so effectively. The objective of this study was to understand the state of current fellowship education on SRH (ie, sexual health, safe sex practices, and fertility) through conducting a national survey of US hematology/oncology fellowship program directors (PDs). METHODS A survey was sent to all PDs of adult hematology/oncology fellowship programs in the United States via online link. PDs who did not complete the survey were sent up to four follow-up emails and a paper mailing. Descriptive statistics and McNemar tests were conducted. RESULTS One hundred-fourteen PDs responded (65%). Fewer programs offered formal instruction on sexual health (49%) and safe sex practices (37%) compared with fertility (75%). Informal training in SRH relied heavily on direct clinical experience (73%-78% of programs
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
This survey of 114 US #hemonc fellowship directors shows less than half offered ANY formal training on sexual health (49%) or safe sex practices (37%). The most common barrier was a perceived lack of experts to teach the content. ➡️ https://t.co/99KPs6Cdrf @DrJennyReese https://t.co/pYJIAheaMi
-
-
Mashup Score: 4The HemOnc Pulse: Drs. Dahiya, Spiegel Discuss CAR-T Secondary Malignancies Risk on Apple Podcasts - 2 month(s) ago
Show The HemOnc Pulse, Ep Drs. Dahiya, Spiegel Discuss CAR-T Secondary Malignancies Risk – Feb 8, 2024
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet-
Episode 1 of CART and secondary malignancies with Saurabh Dahiya and @jayspiegel25 on the #HemOnc Pulse podcast is out. Some updates occurred since we taped this and episode 2 will follow next week. Listen to Ep 1 first right here. @Blood_Cancers https://t.co/nI99NENmwt
-
-
Mashup Score: 9Clinician-Researcher by Day … Podcaster/Social Media Guru by Night? | Blood Cancers Today - 2 month(s) ago
Hematologist-oncologists are increasingly turning to podcasts and social media to learn about new data and to share research.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
Thank you @Blood_Cancers for highlighting the importance of “podcasting” and social media for teaching and disseminating timely information. Appreciate being part of this article. Please subscribe to #HemOnc Pulse podcast everywhere. https://t.co/jcAtru1yo5
-
-
Mashup Score: 11
Susan Parsons, MD, MRP; Andrew Evans, DO, MBA, MSc; and Matthew Maurer, DMSc; discuss the HoLISTIC consortium.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
BIG DATA at its best - The HoLISTIC consortium is answering Qs we never thought we could. @DrAEvens @MaurerStats, Dr. Parsons et al have done the superb work & share w me how it all started. A #HemOnc Pulse exclusive. @Blood_Cancers DON’T miss it. https://t.co/qAEEUBwXfx
-
-
Mashup Score: 5FDA grants accelerated approval to pirtobrutinib - 5 month(s) ago
On December 1, 2023, the Food and Drug Administration granted accelerated approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have received at least two prior lines of therapy, including a BTK inhibitor.
Source: www.fda.govCategories: General Medicine News, Partners & KOLsTweet-
This is an important @US_FDA approval for Chronic Lymphocytic Leukemia patients who have received prior Tx. I’ll be discussing this with @tobyeyre82 on a future #HemOnc Pulse podcast. Stay tuned. https://t.co/MMHnJYJjHu
-
-
Mashup Score: 4Digital Equity in Hematology-Oncology Fellowship Websites: Toward Standardization, Quality, and Transparency - 5 month(s) ago
Improving trainee program websites may help applicants and programs in the era of virtual interviews
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
💻 Increased standardization, quality & transparency in #hemonc fellowship websites would allow applicants to better assess their level of interest in training at a particular program or its fit for them as individuals before applying. 👉 https://t.co/4ZebLfgxpq @richgodby https://t.co/2VTwlG1TN7
-
-
Mashup Score: 4Digital Equity in Hematology-Oncology Fellowship Websites: Toward Standardization, Quality, and Transparency - 6 month(s) ago
Improving trainee program websites may help applicants and programs in the era of virtual interviews
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
💻 Increased standardization, quality & transparency in #hemonc fellowship websites would allow applicants to better assess their level of interest in training at a particular program or its fit for them as individuals before applying. 👉 https://t.co/4ZebLfgxpq @richgodby https://t.co/2VTwlG1TN7
-
-
Mashup Score: 0Optimizing initial therapy of CLL - 6 month(s) ago
Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the specific considerations for optimizing chronic lymphocytic leukemia (CLL) treatment in patients in the frontline setting. These include age, comorbidities, length of treatment (time-limited or continuous), and access to lines of therapy. This interview took place at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2023 meeting, held in Boston, MA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @DrMDavids of @DanaFarber shares insights into optimizing CLL therapy for patients in the front-line setting - a hot topic at this year’s #iwCLL2023 meeting! Check it out here: 👉https://t.co/CAsNBSmvUL #CLLsm #HemOnc @iwCLL #LeuSM
-
-
Mashup Score: 0Non-Malignant Blood Disorders | VJHemOnc - 6 month(s) ago
Explore the latest updates and expert interviews in non-malignant blood disorders on The Non-Malignant Channel by VJHemOnc
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
You may have noticed our logo has changed... 👀🩸 We now have a Non-Malignant Channel! We are committed to providing you with comprehensive insights into #blooddisorders, from #cancers to #nonmalignant conditions 🔬 👉 https://t.co/DCGCNNnXP8 Our regular #HemOnc content will… https://t.co/zZS7eLlMsS https://t.co/HvYGWi1s0S
-
First appearance for @AaronGoodman33 on the #HemOnc Pulse podcast simplifying Castleman Disease. It’s a must listen to understand the challenge and please follow @DavidFajgenbaum on his WK & Journey W it. Here’s a clip from PAPA’s taping. @Blood_Cancers https://t.co/Gis9wVb3SG